Abstract
OBJECTIVES: This research aimed to retrospectively construct and authenticate ultrasomics models using endoscopic ultrasonography (EUS) images for forecasting the pathological grading of pancreatic neuroendocrine tumors (PNETs). METHODS: After confirmation through pathological examination, a retrospective analysis of 79 patients was conducted, including 49 with grade 1 PNETs and 30 with grade 2/3 PNETs. These patients were randomized to the training or test cohort in a 6:4 proportion. The least absolute shrinkage and selection operator (LASSO) algorithm was used to reduce the dimensionality of ultrasomics features derived from standard EUS images. These nonzero coefficient features were retained and applied to construct prediction models via eight machine-learning algorithms. The optimum ulstrasomics model was determined, followed by creating and evaluating a nomogram. RESULTS: Ultrasomics features of 107 were extracted, and only those with coefficients greater than zero were retained. The XGboost ultrasomics model performed exceptionally well, achieving AUCs of 0.987 and 0.781 in the training and test cohorts, respectively. Furthermore, an effective nomogram was developed and visually represented. Finally, the calibration curves, decision curve analysis (DCA) plots, and clinical impact curve (CIC) displayed in the ulstrasomics model and nomogram demonstrated high accuracy. They provided significant net benefits for clinical decision-making. CONCLUSIONS: A novel ulstrasomics model and nomogram were created and certified to predict the pathological grading of PNETs using EUS images. This study has the potential to provide valuable insights that improve the clinical applicability and efficacy of EUS in predicting the grading of PNETs.